companydata.dkcompanydata.dk

CHR. OLESEN PHARMACEUTICALS A/S: Financial statements 2019

CVR: 32090168

Source: annual report 2019, Danish Business Authority

01/10/2018 – 30/09/2019

CHR. OLESEN PHARMACEUTICALS A/S (CVR 32090168) has filed annual accounts for 2019. In 2019, the company reported a gross profit of EUR 1,069,171 and a net result of EUR 474,910 compared with EUR 95,831 the year before. That is an increase of 128.5% compared with the year before. Equity in the 2019 report amounted to EUR 444,408. The solvency ratio was 5.3%. The company had 1 employee in the financial year.

Gross Profit
EUR 1,069,171
Profit/Loss
EUR 474,910
Equity
EUR 444,408
Total Assets
EUR 8,388,357
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019-1.1M EUR475K EUR444K EUR1
2018-468K EUR96K EUR-31K EUR1
2017-529K EUR128K EUR-126K EUR1
2016-395K EUR21K EUR-254K EUR1
2015-326K EUR-130K EUR-295K EUR1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2019

CHR. OLESEN PHARMACEUTICALS A/S: The 2018 annual report is outFeb 7, 2019

CHR. OLESEN PHARMACEUTICALS A/S has published its annual report for 2018. Gross profit came to DKK 467,859, and the net result was DKK 95,831.

About CHR. OLESEN PHARMACEUTICALS A/S

CHR. OLESEN PHARMACEUTICALS A/S is a Danish company of the type Aktieselskab based in Gentofte, founded in 2009. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Christian Dam Olesen, Mads Christian Olesen and Phillip Christian Dam Quitzau Olesen. The board consists of Tobias Facklam (chair), Christian Dam Olesen and Fabian von Volkmann. The company is owned by CHR. OLESEN A/S and SVVF UG & Co. KG. The company has 2 employees (2026). In 2025, the company reported a gross profit of EUR 1,210,782 and a net result of EUR 237,447 compared with EUR 70,556 the year before. Equity in the 2025 report amounted to EUR 1,744,707.

Source: annual report 2025, Danish Business Authority